A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials

Vaccine

Volumn 27, Issue 41, 2009, Pages 5677-5684

  Boge, Thierry ^a   Rémigy, Michel ^b   Vaudaine, Sarah ^c   Tanguy, Jérôme ^c   Bourdet Sicard, Raphaëlle ^c   van der Werf, Sylvie ^d  

^a Centre Hospitalier de Bourg en Bresse   (France)

^b Maison de Retraite Sainte Famille   (France)

^c DANONE RESEARCH   (France)

^d Institut Pasteur   (France)

Author keywords

Actimel; Influenza; Lactobacillus casei DN 114 001; Probiotic; Vaccination

Indexed keywords

ACTIMEL; INFLUENZA VACCINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; YOGHURT;

AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; FEMALE; FERMENTATION; GERIATRIC PATIENT; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LACTOBACILLUS CASEI; MALE; MULTICENTER STUDY; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASON; SEROCONVERSION; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS STRAIN;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DAIRY PRODUCTS; DOUBLE-BLIND METHOD; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOLOGIC FACTORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; LACTOBACILLUS CASEI; MALE; PLACEBOS; PROBIOTICS;

EID: 69249209646     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.094     Document Type: Article

References (31)

1. Jordan R.E., and Hawker J.I. Influenza in elderly people in care homes. BMJ 333 (2006) 1229-1230
2. Vu T., Farish S., Jenkins M., and Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831-1836
3. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., and Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357 (2007) 1373-1381
4. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2006) 1159-1169
5. Kovaiou R.D., Herndler-Brandstetter D., and Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 9 (2007) 1-17
6. Puig-Barbera J., ez-Domingo J., Varea A.B., Chavarri G.S., Rodrigo J.A., Hoyos S.P., and Vidal D.G. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 25 (2007) 7313-7321
7. Gill H., and Prasad J. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 606 (2008) 423-454
8. Nova E., Warnberg J., Gomez-Martinez S., Diaz L.E., Romeo J., and Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr 98 Suppl 1 (2007) S90-S95
9. de Vrese M., Rautenberg P., Laue C., Koopmans M., Herremans T., and Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 44 (2005) 406-413
10. Diancourt L., Passet V., Chervaux C., Garault P., Smokvina T., and Brisse S. Multilocus sequence typing of Lactobacillus casei reveals a clonal population structure with low levels of homologous recombination. Appl Environ Microbiol 73 (2007) 6601-6611
11. Marcos A., Warnberg J., Nova E., Gómez S., Alvarez A., Alvarez R., Mateos J.A., and Cobo J.M. The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress. Eur J Nutr 43 (2004) 381-389
12. Chapat L., Chemin K., Dubois B., Bourdet-Sicard R., and Kaiserlian D. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 34 (2004) 2520-2528
13. Parra D., De Morentin B.M., Cobo J.M., Mateos A., and Martinez J.A. Monocyte function in healthy middle-aged people receiving fermented milk containing Lactobacillus casei. J Nutr Health Aging 8 (2004) 208-211
14. Parra M.D., Martinez de Morentin B.E., Cobo J.M., Mateos A., and Martinez J.A. Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem 60 (2004) 85-91
15. Turchet P., Laurenzano M., Auboiron S., and Antoine J.M. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 7 (2003) 75-77
16. Hickson M., D'Souza A.L., Muthu N., Rogers T.R., Want S., Rajkumar C., and Bulpitt C.J. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335 (2007) 80
17. ICH Expert Working Group. Guideline for good clinical practice. E6(R1), 1-59. 10-6-1996. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceticals for Human use. ICH Harmonised Tripartite Guideline. 7-8-2008. Ref Type: Report.
18. Benaim C., Froger J., Compan B., and Pelissier J. The assessment of autonomy in elderly people. Ann Readapt Med Phys 48 (2005) 336-340
19. Farnworth E.R. The evidence to support health claims for probiotics. J Nutr 138 (2008) 1250S-1254
20. Aggett P.J., Antoine J.M., Asp N.G., Bellisle F., Contor L., Cummings J.H., Howlett J., Müller D.J., Persin C., Pijls L.T., Rechkemmer G., Tuijtelaars S., and Verhagen H. PASSCLAIM: consensus on criteria. Eur J Nutr 44 Suppl 1 (2005) i5-30
21. EMEA. Notes for harmonisation of requirements for influenza vaccine. www.emea.europa.eu/pdfs/human/bwp/021496en.pdf. www emea europa eu/pdfs/human/bwp/021496en pdf 1997.
22. Palmer D.R., Dowle W.R., Coleman M.T., and Schild G.C. Haemagglutination inhibition test. Advanced Laboratory Technicals for Immunological Diagnostic (1975), US Dept Hlth Ed Welfare, Atlanta pp. 25-62
23. de Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., and Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115 (2003) 63-73
24. Wood J.M., Gaines-Das R.E., Taylor J., and Chakraverty P. Comparison of influenza serological techniques by international collaborative study. Vaccine 12 (1994) 167-174
25. Paineau D., Carcano D., Leyer G., Darquy S., Alyanakian M.A., Simoneau G., Bergmann J.F., Brassart D., Bornet F., and Ouwehand A.C. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 53 (2008) 107-113
26. Olivares M., Díaz-Ropero M.P., Sierra S., Lara-Villoslada F., Fonollá J., Navas M., Rodríguez J.M., and Xaus J. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23 (2007) 254-260
27. Maassen C.B.M., and Claassen E. Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity. Vaccine 26 (2008) 2056-2057
28. Coombes J.L., and Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8 (2008) 435-446
29. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8 (2008) 411-420
30. WHO. Influenza vaccines. Wkly Epidemiol Rec 80 (2005) 277-288
31. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J, Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. British Journal of Nutrition June 2009, in press.